Go to content
UR Home

Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation

Leidgens, Verena ; Proske, Judith ; Rauer, Lisa ; Moeckel, Sylvia ; Renner, Kathrin ; Bogdahn, Ulrich ; Riemenschneider, Markus J. ; Proescholdt, Martin ; Vollmann-Zwerenz, Arabel ; Hau, Peter ; Seliger, Corinna


Glioblastoma (GBM) is the most common and malignant type of primary brain tumor and associated with a devastating prognosis. Signal transducer and activator of transcription number 3 (STAT3) is an important pathogenic factor in GBM and can be specifically inhibited with Stattic. Metformin inhibits GBM cell proliferation and migration. Evidence from other tumor models suggests that metformin ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: daten@ur.de
0941 943 -5707

Contact persons